-
Gov’t streams £5m into obesity research unit
pharmatimes
August 21, 2017
The Department of Health has announced £5 million of funding for a new obesity policy research unit at University College London, tasked with investigating the deeper causes of childhood obesity and supporting delivery of the childhood obesity plan.
-
NICE bars obesity pill from routine NHS use
pharmatimes
August 01, 2017
Cost regulators for NHS treatments in England and Wales are standing by their position that Orexigen’s weight loss pill Mysimba can not be recommended as a cost-effective treatment option.
-
Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity
worldpharmanews
July 31, 2017
the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment.
-
Rhythm Expands Phase 2 Clinical Trials of Setmelanotide for the Treatment of Bardet-Biedl Syndrome O
americanpharmaceuticalreview
May 18, 2017
Rhythm announced the expansion of the company's Phase 2 clinical trials of setmelanotide to the treatment of Bardet-Biedl syndrome (BBS) obesity.
-
Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Dis
americanpharmaceuticalreview
May 12, 2017
Rhythm announced the U.S. Food and Drug Administration (FDA) has expanded a previously granted Breakthrough Therapy Designation (BTD) for setmelanotide, the company's novel melanocortin-4 receptor (MC4R) agonist.
-
Next gov’t must ‘get to grips’ with obesity, warns Alliance
pharmatimes
May 08, 2017
The next government must address the UK’s obesity epidemic or risk “plunging the NHS into irreversible financial trouble”, the Obesity Health Alliance has warned.
-
PHE sets sugar targets to help fight obesity
pharmatimes
March 31, 2017
Public Health England (PHE) has published new guidelines designed to cut the amount of sugar in nine products categories, including yoghurt, breakfast cereals and biscuits, under a bid to reduce consumption by 5 percent this year and overall by a fifth by
-
Gene Variant From Africa Linked to Black Obesity
drugs.com
March 15, 2017
Researchers say they've identified an Africa-specific gene variant associated with obesity.
-
Global obesity has reached pandemic levels: Report
biospectrumasia
March 15, 2017
Urgent action is required to limit the global fallout from rising obesity levels, according to a report published by Aetna International
-
Sulforaphane, a phytochemical in broccoli sprouts, ameliorates obesity
worldpharmanews
March 08, 2017
Sulforaphane, a phytochemical contained in broccoli sprouts at relatively high concentrations, has been known to exert effects of cancer prevention by activating a transcription factor.